Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2006
10/04/2006CN1277545C Use of bisphosphonates in preparing medicine for the treatment of bone metastasis associated with prostate cancer
10/04/2006CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
10/04/2006CN1277536C Use of L-arginine in preparing medicine for assisting reducing blood pressure
10/04/2006CN1277532C Pearl powder soft capsule
10/03/2006US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria
10/03/2006US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives
10/03/2006US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier
10/03/2006US7115648 use for treating type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity
10/03/2006US7115637 Inhibitors of p38
10/03/2006US7115633 Benzosuberonylpiperdine compounds as analgesics
10/03/2006US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
10/03/2006US7115630 Metabotropic glutamate receptor antagonists
10/03/2006US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction
10/03/2006US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction
10/03/2006US7115616 Pyrimidinone compounds
10/03/2006US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline
10/03/2006US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115597 Tyrosine kinase inhibitors
10/03/2006US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines
10/03/2006US7115575 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/03/2006US7115569 Exendins, exendin agonists, and methods for their use
10/03/2006US7115559 Administering factor XIII to patients afflicted with bleeding due to a coumarin anticoagulant-induced vitamin K deficiency
10/03/2006US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype
10/03/2006US7115392 Polynucleotides encoding human vascular endothelial growth factor 2
10/03/2006US7115279 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
10/03/2006US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation
10/03/2006CA2489834C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
10/03/2006CA2394200C Novel forms of pravastatin sodium
10/03/2006CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
10/03/2006CA2247946C Anticachectic composition
10/03/2006CA2208611C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
10/03/2006CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/2006
09/29/2006CA2552308A1 Anorectic agent and air regulator for diet
09/28/2006WO2006102674A2 Diphenylheterocycle cholesterol absorption inhibitors
09/28/2006WO2006101663A1 Composition and method for modulating hydrogen ion physiology
09/28/2006WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors
09/28/2006WO2006101407A1 Injection formulation containing the elements selenium and iodine
09/28/2006WO2006101118A1 Application of d-psicose to suppression of abnormal circadian increase in blood glucose level
09/28/2006WO2006101108A1 Novel cyclic aminophenylalkanoic acid derivative
09/28/2006WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006WO2006100355A1 Fat-burning soup composition for persons wishing to lose weight
09/28/2006WO2006100181A2 New salt and polymorphs of a dpp-iv inhibitor
09/28/2006WO2006099943A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
09/28/2006WO2006099941A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
09/28/2006WO2006099940A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
09/28/2006WO2006099706A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1
09/28/2006WO2006079719A3 Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same
09/28/2006WO2006075023A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
09/28/2006WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors
09/28/2006WO2006046156A3 Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same
09/28/2006WO2005080384A3 Benzimidazole derivative and use as aii receptor antagonist
09/28/2006WO2005040157A3 Novel mch receptor antagonists
09/28/2006US20060217529 Method for Producing Insulin From a Natural Source and Insulin Produced by Said Method
09/28/2006US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
09/28/2006US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
09/28/2006US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor
09/28/2006US20060217388 Phthalazine derivatives for treating inflammatory diseases
09/28/2006US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
09/28/2006US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
09/28/2006US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels
09/28/2006US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
09/28/2006US20060217372 Diaryl ethers as opioid receptor antagonist
09/28/2006US20060217364 Beta-lactamyl vasopressin V1a antagonists
09/28/2006US20060217353 24-sulfoximine vitamin D3 compounds
09/28/2006US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties
09/28/2006US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same
09/28/2006US20060217296 For treatment and/or prevention of loss of body weight and body fat, cachexia, stimulation of appetite, food intake, stimulation of weight gain, and/or increasing body fat mass
09/28/2006US20060216739 Insulin-like growth factor binding protein
09/28/2006US20060216362 Remedy
09/28/2006US20060216354 Vector for oral administration
09/28/2006US20060216301 Kdr peptides and vaccines containing the same
09/28/2006DE102005027150A1 Pyrimidincarbonsäure-Derivate und ihre Verwendung Pyrimidinecarboxylic acid derivatives and their use
09/28/2006DE102005012873A1 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments
09/28/2006DE102005012872A1 Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-pyrrolidino-benzimidazoles, process for their preparation and their use as medicaments
09/28/2006DE102005012832A1 Arzneimittel aus Pflanzenextrakten als Lipaseinhibitor Medicinal plant extracts as a lipase inhibitor
09/28/2006DE102004039533B4 Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexylmethoxy-acetic acid derivatives having substituents, processes for their preparation and their use as medicaments
09/28/2006CA2602241A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
09/28/2006CA2602236A1 Use of amino-substituted benzimidazoles
09/28/2006CA2602233A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
09/28/2006CA2602229A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
09/28/2006CA2601855A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1
09/28/2006CA2600550A1 Composition and method for modulating hydrogen ion physiology
09/28/2006CA2600074A1 Novel cyclic aminophenylalkanoic acid derivative
09/28/2006CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006CA2580857A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
09/27/2006EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/27/2006EP1704861A1 Lipase inhibitor
09/27/2006EP1704857A1 Abca1 stabilizer
09/27/2006EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists
09/27/2006EP1703795A2 Beta vulgaris-based products
09/27/2006EP1549334B1 Pharmaceutical composition comprising a retro-inverso isomer peptide
09/27/2006EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators
09/27/2006EP1421078B1 Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes
09/27/2006EP1383757B1 Antagonists of mcp-1 function and methods of use thereof
09/27/2006EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents